Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends-Reference-Cited by-同舟云学术

Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends

Published:2018-12 Issue: Volume:71 Page:32-38
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Edwards P.,Davidson M.,Calamai V.,Cunningham D.,Starling N.^ORCID

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference68 articles.

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide. IARC CancerBase, Int Agency Res Cancer 2014 [accessed 16/12/14].

2. A global assessment of the oesophageal adenocarcinoma epidemic;Edgren;Gut,2013

3. SEER Cancer Statistics Review, 1975-2015. https://seer.cancer.gov/csr/1975_2015/.

4. Which interval is most crucial to presentation and survival in gastroesophageal cancer: a systematic review;Lee;J Adv Nurs,2017

5. Screening for oesophageal cancer;Lao-Sirieix;Nat Rev Clin Oncol,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolving strategies for the management of patients with metastatic gastric cancer: A narrative review and expert opinion;Frontiers in Medicine;2022-12-15

2. Apatinib in the treatment of gastric cancer in Henan Province: a multicenter prospective real-world observational study (Ahead-HAP01);Annals of Translational Medicine;2022-12

3. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study;European Journal of Cancer;2020-11

4. The relationship between the number of examined lymph nodes and the efficacy of chemotherapy for gastric cancer;Surgery Today;2019-12-06

5. Apigenin Inhibits IL-6 Transcription and Suppresses Esophageal Carcinogenesis;Frontiers in Pharmacology;2019-09-11